Transparent pricing Membership-free US-sourced ingredients Unlimited 24/7 support 100% online State-licensed pharmacies Clinician-led care

Our partner pharmacies have served 100,000+ patients

$129/month

Compounded · GLP-1 Care for Perimenopause

Semaglutide Injection

Our partner pharmacies
have served 100,000+ patients

For perimenopause and menopause weight gain that
feels different after 40.

See if I qualify

No charge today Takes about 3 minutes

  • Licensed medical providers
  • State-licensed pharmacies
  • Same-day prescriptions
  • 2-day shipping
Compounded semaglutide injection — online telehealth care from Cypress Health
  • 2-day shipping · direct-to-door
  • Cancel anytime before your next ship date
  • Includes clinician oversight, dose escalation, and side-effect support
Your care
Clinician-ledCare
State-LicensedCompounding Pharmacies
HIPAACompliant
Available inAll 50 US states

Simple online
telehealth care, built around you.

Start your assessment

3-minute screener · No commitment

1
Complete your intake
Tell us about your health history, goals, symptoms, and what's changed. This takes less than 3 minutes.
Start Now
2
Get provider review
A licensed U.S. provider reviews your information and determines whether treatment is appropriate — typically within 24 hours.
Learn More
3
Start your plan
If eligible, your plan may include compounded GLP-1 medication with pharmacy coordination, ongoing oversight, and direct-to-door delivery.

Medical oversight by Arora Health

Your care is reviewed and overseen by board-certified, U.S.-licensed physicians at Arora Health & Aesthetics — our independent medical partner, with clinician coverage in all 50 states.

Dr. Sean Arora, Co-Founder and CEO of Arora Health & Aesthetics

Dr. Sean Arora

Arora Co-Founder & CEO

  • Board-certified physician
  • Licensed in all 50 states

Dr. Sean Arora is a board-certified physician and the founder of Arora Health & Aesthetics, bringing deep expertise in wellness, family medicine, and telehealth innovation.

He leads one of the nation's most comprehensive medical oversight and compliance networks, supporting clinics through full-spectrum medical directorship, nationwide telehealth provider coverage, and evidence-based protocol development across peptides, hormone optimization, weight loss, regenerative medicine, and aesthetic treatments.

Known for his forward-thinking approach to patient safety and scalable clinical operations, Dr. Arora partners closely with medical spas, wellness clinics, and telehealth organizations to ensure responsible, compliant, and impactful care. Licensed in all 50 states, he is dedicated to expanding access to high-quality wellness services through innovation, leadership, and patient-centered standards.

Dr. Shannon Arora, Chief Medical Officer of Arora Health & Aesthetics

Dr. Shannon Arora

Chief Medical Officer

  • Hospital-trained physician
  • Preventive & longevity medicine

Dr. Shannon Arora is a physician dedicated to making a meaningful impact on patient health through both traditional medicine and proactive wellness care.

With experience as a hospitalist, she brings a strong clinical foundation shaped by work in hospitals and nursing homes, offering a broad perspective on patient care across diverse settings. While her early career focused on acute care, Dr. Arora recognized an opportunity to create a more proactive, personalized approach within the health, wellness, and longevity space. She now focuses on optimizing patient health through advanced wellness therapies, preventative medicine, and longevity-focused care, helping patients improve energy, confidence, and overall quality of life.

As Chief Medical Officer, Dr. Arora is passionate about advancing innovation in regenerative medicine and wellness, while helping both patients and organizations achieve better outcomes through thoughtful, patient-centered care.

Why semaglutide

A first step most women tolerate well.

Compounded semaglutide injection for perimenopause weight loss

Semaglutide is a prescription medication, not a supplement. Cypress offers compounded semaglutide by online prescription — reviewed by a licensed U.S. provider who determines whether it’s appropriate for you.

The active ingredient — semaglutide — has been studied extensively for weight management. The dose ramp is gentle, the side-effect profile is well understood, and most women find compounded semaglutide tolerable from the start.

For women in midlife, semaglutide is often the first GLP-1 we recommend. If response plateaus or doesn't reach goals, your clinician can talk through whether tirzepatide or a different protocol might fit better.

Whether semaglutide is right for you depends on your medical history, current medications, and goals. Your clinician will determine that. The intake is the first step.

A measured start. Adjusted as you go.

1
Weeks 1–4 · Starting dose
0.25 mg once weekly. The starting dose is intentionally low to let your body adjust; mild GI symptoms are common in the first week or two and typically settle.
2
Weeks 5+ · Dose escalation
Your clinician adjusts your dose — typically 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg over time, based on response, tolerance, and goals.
3
Ongoing · Care, not just refills
Your plan includes ongoing clinician oversight, dose adjustment, side-effect support, and lab review when needed.

Side effects & safety

What to know before you start.

Woman reviewing health information at home

Most common: nausea, decreased appetite, mild diarrhea, constipation, fatigue. Typically dose-related and most pronounced in the first week of each new dose.

Less common but important: pancreatitis, gallbladder issues, low blood sugar (especially if you also take insulin or sulfonylureas). Tell your clinician about all current medications.

Muscle mass during treatment: GLP-1 therapy can be associated with loss of lean mass, particularly in women in midlife. Your clinician will discuss strategies to protect muscle — typically resistance training and adequate dietary protein — as part of your care plan.

Not appropriate if: you have a personal or family history of medullary thyroid carcinoma or MEN2; you're pregnant, planning pregnancy, or breastfeeding; or you have severe GI disease or end-stage organ disease.

Questions

Answers to
common questions.

How is compounded semaglutide prepared?
Compounded by a licensed 503A pharmacy on a per-patient basis.
Compounded semaglutide is prepared by a state-licensed U.S. pharmacy operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. Each preparation is dispensed per-patient based on a licensed clinician's prescription. Compounded preparations are not interchangeable with branded medications and may differ in formulation, strength, and clinical profile. Your clinician will help determine whether compounded semaglutide is appropriate for your specific health profile.
What should I expect after starting?
Everyone responds differently — your clinician tracks how you respond over time.
Everyone responds differently. Your clinician monitors how your body responds over time and adjusts your plan accordingly. Whether and how you respond depends on your individual health, and your clinician will review your progress with you. The largest published trial of injectable semaglutide for weight management — STEP 1 (Wilding et al., NEJM 2021) — showed an average ~14.9% body weight loss over 68 weeks at the 2.4 mg weekly dose. Outcomes from clinical trials of branded products cannot be directly attributed to compounded preparations. Your individual response depends on dose, time, lifestyle, and biology.
When am I charged?
Not until a clinician confirms your eligibility — typically within 24–48 hours.
You're not charged when you submit your assessment. Your card is securely saved while a licensed clinician reviews your case, typically within 24 to 48 hours. If you're approved, you'll receive an email confirmation before any charge is processed. If you're not approved, you're not charged at all.
Will I need to stay on treatment after I reach my goal?
Most people regain weight without a structured maintenance plan. We plan that step with you, not around you.
This is one of the most important conversations you'll have with your clinician. The available evidence — including the STEP 4 withdrawal trial (Rubino et al., JAMA 2021) — shows that most people regain weight when they stop GLP-1 therapy without a structured maintenance plan. Some women step down to a lower maintenance dose; some wean off with continued resistance training and protein-forward eating to preserve lean mass; some choose to continue at full dose. There's no single right answer, and the right path is decided with you.
Can I cancel?
Cancel anytime before your next ship date.
Your monthly subscription can be cancelled anytime before your next ship date — there's no long-term commitment. Medication, supplies, and shipping are all included while you're active.
Is insurance required?
No — transparent flat-rate pricing, no hidden fees.
No. Cypress offers transparent, flat-rate pricing without insurance and no hidden fees. Medication, supplies, and shipping are all included.
Can I use my FSA/HSA?
Yes — itemized receipts provided for self-submission.
Yes. HSA and FSA cards are accepted on any plan. We also provide itemized receipts in case you need to self-submit to your benefits provider.

See if semaglutide is right for you.

The 3-minute medical screener is free. If you're a candidate, your clinician typically follows up within 24 hours.

See if I qualify
No charge today See if I qualify